What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to inform investors about Philip Morris International's (PM) increased ownership in Vectura Group plc, specifically announcing the acquisition of an additional 6.55% stake in Vectura through market purchases.

How does this increased stake in Vectura affect PM's overall acquisition plan?

The increased stake of approximately 29.16% in Vectura signifies substantial progress in PM's tender offer to acquire the company. It demonstrates PM's active commitment to consolidating its ownership and moving closer to completing the acquisition, which is part of its strategy to expand its presence in the respiratory drug delivery market.

Where can I find more information about the Vectura tender offer?

Additional information regarding the tender offer for Vectura Group plc shares can be found on Philip Morris International's official website, under the section titled 'Offer to Acquire Vectura Group plc.'

Are the disclosures in this 8-K considered 'filed' for legal purposes?

No, in accordance with General Instruction B.2 of Form 8-K, the information in this Current Report, including Exhibit 99.1, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or subject to the liabilities of that section. It is also not automatically incorporated into other filings unless specifically referenced.

PM 8-K: Regulation FD — Aug 19, 2021

Summary

Philip Morris International Inc. (PM) filed an 8-K on August 19, 2021, primarily to update investors on its ongoing tender offer for Vectura Group plc. The company announced it had acquired an additional 6.55% stake in Vectura through market purchases outside the U.S. on August 18, 2021. This brings PM's total ownership in Vectura to approximately 29.16%, a significant increase from its previous holdings and a step closer to its stated tender offer goals. This increased stake signals continued strategic progress in PM's acquisition of Vectura, a move aimed at expanding its respiratory drug delivery business. Investors should view this as a positive development demonstrating PM's commitment to executing its acquisition strategy. Further details on the tender offer and its implications can be found on the company's website.

Key Highlights

1Philip Morris International (PM) acquired an additional ~6.55% of Vectura Group plc shares on August 18, 2021.
2PM's total ownership in Vectura now stands at approximately 29.16%.
3The additional shares were acquired through market purchases outside the United States.
4This update relates to the ongoing tender offer by PM for Vectura Group plc.
5The press release was issued in the UK via the Regulatory News Service.
6PM is actively increasing its stake in Vectura, indicating progress in the acquisition process.

Philip Morris International Inc. 8-K Report, Regulation FD Disclosure (Aug 19, 2021)

Summary

Key Highlights

Frequently Asked Questions